Literature DB >> 20839133

Predictions of verbal episodic memory in persons with Alzheimer's disease.

Maureen Schmitter-Edgecombe1, Adriana M Seelye.   

Abstract

This study examined awareness of memory problems and memory self-monitoring abilities in individuals with Alzheimer's disease (AD). Participants were 20 individuals with AD and 20 older adult controls. A global performance-prediction paradigm, which required participants to predict the number of words they would remember both prior to and after completing a list-learning memory task, was used as the online assessment measure. Offline assessment of memory involved contrasting self-ratings provided by participants about the frequency of everyday memory failures with ratings from knowledgeable informants. As expected, participants with AD demonstrated poorer recall for the word list than did controls. Participants with AD were also less accurate than controls in their preexperience memory predictions, and findings from the offline assessment method similarly revealed that the AD group overestimated their everyday memory abilities. Despite showing impaired understanding of personal memory ability, the AD group successfully modified their postexperience memory predictions so that they were more accurate following task exposure, demonstrating accurate memory self-monitoring abilities. These findings highlight the complex and multidimensional nature of metamemory. The findings further suggest that while AD patients appear able to immediately benefit from task experience, they have difficulty creating lasting awareness of memory abilities.

Entities:  

Mesh:

Year:  2010        PMID: 20839133     DOI: 10.1080/13803395.2010.507184

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  8 in total

1.  Alzheimer's disease can spare local metacognition despite global anosognosia: revisiting the confidence-accuracy relationship in episodic memory.

Authors:  David A Gallo; Stefanie J Cramer; Jessica T Wong; David A Bennett
Journal:  Neuropsychologia       Date:  2012-06-18       Impact factor: 3.139

2.  The use of metacognitive strategies to decrease false memories in source monitoring in patients with mild cognitive impairment.

Authors:  Rebecca G Deason; Neil A Nadkarni; Michelle J Tat; Sean Flannery; Bruno Frustace; Brandon A Ally; Andrew E Budson
Journal:  Cortex       Date:  2017-02-03       Impact factor: 4.027

3.  Response bias and response monitoring: Evidence from healthy older adults and patients with mild Alzheimer's disease.

Authors:  Rebecca G Deason; Michelle J Tat; Sean Flannery; Prabhakar S Mithal; Erin P Hussey; Eileen T Crehan; Brandon A Ally; Andrew E Budson
Journal:  Brain Cogn       Date:  2017-09-17       Impact factor: 2.310

4.  Memory awareness disruptions in amnestic mild cognitive impairment: comparison of multiple awareness types for verbal and visuospatial material.

Authors:  Anthony J Ryals; Jonathan T O'Neil; M-Marsel Mesulam; Sandra Weintraub; Joel L Voss
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2018-08-06

5.  Metamemory monitoring in Alzheimer's disease A systematic review.

Authors:  Michelle Brandt; Raquel Luiza Santos de Carvalho; Tatiana Belfort; Marcia Cristina Nascimento Dourado
Journal:  Dement Neuropsychol       Date:  2018 Oct-Dec

6.  Self-awareness and traumatic brain injury outcome.

Authors:  Kayela Robertson; Maureen Schmitter-Edgecombe
Journal:  Brain Inj       Date:  2015-04-27       Impact factor: 2.311

7.  Insight into memory and functional abilities in individuals with amnestic mild cognitive impairment.

Authors:  Lisa A Chudoba; Maureen Schmitter-Edgecombe
Journal:  J Clin Exp Neuropsychol       Date:  2020-09-22       Impact factor: 2.475

8.  Retrospective metamemory monitoring of semantic memory in community-dwelling older adults with subjective cognitive decline and mild cognitive impairment.

Authors:  Susan Y Chi; Elizabeth F Chua; Dustin W Kieschnick; Laura A Rabin
Journal:  Neuropsychol Rehabil       Date:  2020-10-26       Impact factor: 2.928

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.